1. Goldstein SL. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 2012;33:131-7.
2. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl 2006;33:S3-7.
3. Tandukar S, Rondon-Berrios H, Weisbord SD. Intravascular Iodinated Contrast Is an Independent Cause of Acute Kidney Injury Following Coronary Angiography. South Med J 2019;112:541-6.
4. Windpessl M, Kronbichler A. Pro: Contrast-induced nephropathyshould we try to avoid contrast media in patients with chronic kidney disease? Nephrol Dial Transplant 2018;331317-9.
6. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007;71:1028-35.
10. Yim HE. Neutrophil Gelatinase-Associated Lipocalin and Kidney Diseases. Child Kidney Dis 2015;19:79-88.
17. Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, et al. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 2016;90:212-21.
18. Uber AM, Sutherland SM. Acute kidney injury in hospitalized children: consequences and outcomes. Pediatr Nephrol 2018.
19. Cleper R, Shavit I, Blumenthal D, Reisman L, Pomeranz G, Haham A, et al. Neonatal acute kidney injury: recording rate, course, and outcome: one center experience. J Matern Fetal Neonatal Med 2019;32:3379-85.
24. Paul KM, Johnson J, Garwe T, Sarwar Z, Motghare P, Daly W, et al. Computed Tomography with Intravenous Contrast Is Not Associated with Development of Acute Kidney Injury in Severely Injured Pediatric Patients. Am Surg 2019;85:e1-e5.
27. McDonald JS, McDonald RJ, Tran CL, Kolbe AB, Williamson EE, Kallmes DF. Postcontrast Acute Kidney Injury in Pediatric Patients: A Cohort Study. Am J Kidney Dis 2018;72:811-8.
28. Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, noninferiority trial. Lancet 2017;389:1312-22.
29. Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med 2018;378:603-14.
30. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-8.
31. Azzalini L, Vilca LM, Lombardo F, Poletti E, Laricchia A, Beneduce A, et al. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media. Int J Cardiol 2018;273:69-73.
32. Kronbichler A, Shin JI, Windpessl M. What is left to prevent contrast-induced acute kidney injury? No difference between low and iso-osmolar contrast media. Int J Cardiol 2018;273:94-5.
33. Media ACoDaC. ACR Manual On Contrast Media. 2018.
36. McDonald JS, Leake CB, McDonald RJ, Gulati R, Katzberg RW, Williamson EE, et al. Acute Kidney Injury After Intravenous Versus Intra-Arterial Contrast Material Administration in a Paired Cohort. Invest Radiol 2016;51:804-9.
37. Liu Y, Li H, Chen S, Chen J, Tan N, Zhou Y, et al. Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency. J Am Heart Assoc 2016;5.
38. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999;33:403-11.
39. Mattathil S, Ghumman S, Weinerman J, Prasad A. Use of the RenalGuard system to prevent contrast-induced AKI: A metaanalysis. J Interv Cardiol 2017;30:480-7.
40. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
41. Investigators ACT. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011;124:1250-9.
43. Phan H, Nahata MC. Clinical uses of dexmedetomidine in pediatric patients. Paediatr Drugs 2008;10:49-69.
44. Billings FTt, Chen SW, Kim M, Park SW, Song JH, Wang S, et al. alpha2-Adrenergic agonists protect against radiocontrastinduced nephropathy in mice. Am J Physiol Renal Physiol 2008;295:F741-8.
45. Bayram A, Ulgey A, Baykan A, Narin N, Narin F, Esmaoglu A, et al. The effects of dexmedetomidine on early stage renal functions in pediatric patients undergoing cardiac angiography using nonionic contrast media: a double-blind, randomized clinical trial. Paediatr Anaesth 2014;24:426-32.
47. McCullough PA. Multimodality prevention of contrast-induced acute kidney injury. Am J Kidney Dis 2008;51:169-72.
48. Lakhal K, Ehrmann S, Robert-Edan V. Iodinated Contrast Medium Renal Toxicity: The Phantom Menace or Much Ado About Nothing? Crit Care Med 2017;45:e745-e6.
49. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008;191:376-82.
51. McDonald JS, McDonald RJ, Williamson EE, Kallmes DF. Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study. Radiology 2017;285:414-24.